<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="6243">
  <stage>Registered</stage>
  <submitdate>11/06/2014</submitdate>
  <approvaldate>11/06/2014</approvaldate>
  <nctid>NCT02162615</nctid>
  <trial_identification>
    <studytitle>Restorelle® Mesh Versus Native Tissue Repair for Prolapse</studytitle>
    <scientifictitle>Restorelle® Transvaginal Mesh Versus Native Tissue Repair for Treatment of Pelvic Organ Prolapse, Restorelle 522 Study</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>SU014</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Pelvic Organ Prolapse</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2>Research that is not of generic health relevance and not applicable to specific health categories listed above</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Other renal and urogenital disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Fetal medicine and complications of pregnancy</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Childbirth and postnatal care</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Restorelle Direct Fix A
Treatment: devices - Restorelle Direct Fix P
Treatment: surgery - Native Tissue Repair Anterior
Treatment: surgery - Native Tissue Repair Posterior

Restorelle Direct Fix A - Anterior/Apical prolapse repair with Restorelle Direct Fix A

Native Tissue Repair Anterior - Anterior/Apical prolapse repair with native tissue only

Restorelle Direct Fix P - Posterior/Apical prolapse repair with Restorelle Direct Fix P

Native Tissue Repair Posterior - Posterior/Apical prolapse repair with native tissue only


Treatment: devices: Restorelle Direct Fix A


Treatment: devices: Restorelle Direct Fix P


Treatment: surgery: Native Tissue Repair Anterior


Treatment: surgery: Native Tissue Repair Posterior


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Recurrence of Prolapse - Recurrent Prolapse measured anatomically at the target compartment by leading edge of prolapse beyond the hymenal ring by POP-Q examination, or additional surgical treatment for pelvic organ prolapse in the target vaginal compartment(s), or patient reporting symptoms of vaginal bulging.</outcome>
      <timepoint>12 Month</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Rate of device and procedure related serious adverse events</outcome>
      <timepoint>12 Month</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Recurrence of Prolapse - Recurrent prolapse is measured anatomically by leading edge of prolapse in the target compartment at or beyond the hymenal ring by POP-Q examination, or additional surgical treatment for pelvic organ prolapse in the target vaginal compartment(s), or patient reporting symptoms of vaginal bulging.</outcome>
      <timepoint>12 Month</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Recurrence of Prolapse - Recurrent Prolapse is measured anatomically by leading edge of prolapse in the target compartment beyond the hymenal ring by POP-Q examination, or additional surgical treatment for pelvic organ prolapse in the target vaginal compartment(s), or patient reporting symptoms of vaginal bulging.</outcome>
      <timepoint>36 Month</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Recurrence of Prolapse - Recurrent Prolapse measured anatomically by leading edge of prolapse in the target compartment at or beyond the hymenal ring by POP-Q examination, or additional surgical treatment for pelvic organ prolapse in the target vaginal compartment(s), or patient reporting symptoms of vaginal bulging.</outcome>
      <timepoint>36 Month</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Device or Procedure related AEs of interest</outcome>
      <timepoint>36 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Female at least 18 years of age

          -  Subject has pelvic organ prolapse with leading edge at or beyond the hymen. At or
             beyond the hymen is defined as POP-Q scores of Ba =0 and C= -1/2 tvl or Bp =0 and C=
             -1/2 tvl

          -  Subject reports a bothersome bulge they can see or feel per PFDI-20 question 3,
             response of 2 or higher (i.e. responses of "somewhat", "moderately" or "quite a bit")

          -  Subject is willing to provide written informed consent

          -  Subject is willing and able to comply with the follow-up regimen</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Female</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Subject is pregnant or intends to become pregnant during the study

          -  Subject has an active or chronic systemic infection including any gynecologic
             infection, untreated urinary tract infection (UTI), or tissue necrosis

          -  Subject has a history of pelvic organ cancer (e.g. uterine, ovarian, bladder, or
             cervical)

          -  Subject has had prior or is currently undergoing radiation, laser therapy, or
             chemotherapy in the pelvic area

          -  Subject has taken systemic steroids (within the last month), or immunosuppressive or
             immunomodulatory treatment (within the last 3 months)

          -  Subject has a systemic connective tissue disease (e.g. scleroderma, systemic lupus
             erythematosus (SLE), Marfan syndrome, Ehlers Danlos, collagenosis, polymyositis or
             polymyalgia rheumatica)

          -  Subject has chronic systemic pain that includes the pelvic area or chronic focal pain
             that involves the pelvis

          -  Subject has uncontrolled diabetes mellitus (DM)

          -  Subject has a known neurologic or medical condition affecting bladder function (e.g.
             multiple sclerosis, spinal cord injury, or stroke with residual neurologic deficit)

          -  Subject is seeking obliterative vaginal surgery as treatment for pelvic organ prolapse
             (colpocleisis)

          -  Subject is not able to conform to the modified dorsal lithotomy position

          -  Subject is currently participating in or plans to participate in another device or
             drug study during this study

          -  Subject has a known sensitivity to polypropylene

          -  Subject has had previous prolapse repair with mesh in the target compartment(s)

          -  Subject is planning to undergo a concomitant prolapse repair in a non-target
             compartment with anything other than native tissue repair</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/08/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>892</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/11/2021</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,QLD</recruitmentstate>
    <hospital>Centre for Advanced Reproductive Endosurgery - St Leonards</hospital>
    <hospital>Mater Pelvic Health - Pimlico</hospital>
    <postcode>2065 - St Leonards</postcode>
    <postcode>4812 - Pimlico</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>California</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Colorado</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Connecticut</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Delaware</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>District of Columbia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Idaho</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Maryland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Massachusetts</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Michigan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Nebraska</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New Jersey</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New York</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>North Carolina</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Ohio</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Pennsylvania</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>South Dakota</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Tennessee</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Texas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Vermont</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Virginia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Washington</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Leuven</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Ontario</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Quebec</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Lille</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Nimes</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Amsterdam</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Bilthoven</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Breda</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Haarlem</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Maastricht</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Nieuwegein</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Zwolle</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Coloplast A/S</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to collect information on the safety and effectiveness of
      Restorelle Direct Fix mesh and the surgical procedure to implant Restorelle. These results
      will be compared to the safety and effectiveness results in patients who have native tissue
      repair (without mesh) as their pelvic organ prolapse treatment.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02162615</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>James Lukban, DO</name>
      <address>The Pelvic Solutions Center</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Lisa Draper</name>
      <address />
      <phone />
      <fax />
      <email>usldr@coloplast.com</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>